COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
Author(s)
Hall, VG; Teh, BW;
Details
Publication Year 2023-08-04,Volume 228,Issue #Suppl 1,Page S55-S69
Journal Title
Journal of Infectious Diseases
Publication Type
Review
Abstract
Patients with cancer demonstrate an increased vulnerability for infection and severe disease by SARS-CoV-2, the causative agent of COVID-19. Risk factors for severe COVID-19 include comorbidities, uncontrolled disease, and current line of treatment. Although COVID-19 vaccines have afforded some level of protection against infection and severe disease among patients with solid tumors and hematologic malignancies, decreased immunogenicity and real-world effectiveness have been observed among this population compared with healthy individuals. Characterizing and understanding the immune response to increasing doses or differing schedules of COVID-19 vaccines among patients with cancer is important to inform clinical and public health practices. In this article, we review SARS-CoV-2 susceptibility and immune responses to COVID-19 vaccination in patients with solid tumors, hematologic malignancies, and those receiving hematopoietic stem cell transplant or chimeric-antigen receptor T-cell therapy.
Publisher
Oxford University Press
Keywords
Humans; COVID-19 Vaccines; *Receptors, Chimeric Antigen; *covid-19; SARS-CoV-2; *Neoplasms/complications/therapy; *Hematologic Neoplasms/complications/therapy; Vaccination; Immunity; *Hematopoietic Stem Cell Transplantation; chimeric-antigen receptor T-cell therapy; hematologic malignancies; hematopoietic stem cell transplant; mRNA COVID-19 vaccines; solid tumors
Department(s)
Infectious Diseases
PubMed ID
37539765
Open Access at Publisher's Site
https://doi.org/10.1093/infdis/jiad174
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-10-19 07:23:14
Last Modified: 2023-10-19 07:23:32

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙